Avant Bio

Venture Capital Exempt reporting adviser

Legal name: Avant Bio LLC

New York, NY Website LinkedIn

AUM

$56.3M
Private fund assets

Private funds

1
Venture Capital 1

Private fund assets

$56.3M
Gross asset value

Employees

—

Last Form D raise

Dec 2024
Most recent fund filing

From SEC Form ADV filing (filed Mar 31, 2026). View on SEC

People(1)

Owners and executive officers named on the firm's SEC Form ADV.

Funds(1)

Private funds reported on Form ADV, with amounts raised from the funds' SEC Form D filings.

FundTypeGross assetsRaised (Form D)InvestorsLast Form DRecency
Avant Bio Fund II LPVenture Capital$56.3M$57.5M12Dec 2024Cool

Board seats

Companies whose SEC Form D filings name one of this firm's people as a director, matched by name and office ZIP code.

No board seats matched from SEC filings yet.

Regulatory identifiers

CRD number
327673
SEC file number
802-128768

Sources